Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts: Monotherapy Versus Combined Therapy

NCT05291845 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05291845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts: Monotherapy Versus Combined Therapy
Lead sponsor
Zagazig University
Phase
Phase 2
Overall status
Recruiting
Start date
April 3, 2022
Completion date
December 6, 2025
Enrollment
162 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus, warts